(Q40090535)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

review article

1 reference

title

Systemic lupus erythematosus: 25 years of treatment related to immunopathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

27 October 2019

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

2

P Youinou

1 reference

27 October 2019

W J Morrow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M L Snaith

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 July 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

206-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

A comparison of chloroquine and gold in the treatment of lupus erythematosus

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Treatment of lupus erythematosus with vitamin B12; preliminary report of 4 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Treatment of lupus erythematosus with mepacrine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Corticotropin and cortisone treatment for systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

An experimental study of haemolytic disease of the newborn due to isoimmunization of pregnancy: II. Report of an attempt to produce anti-red cell isoantibodies in guinea-pigs, together with a note on the blood picture of one-day-old guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Auto-antibodies in Hashimoto's disease (lymphadenoid goitre)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Study of thymic factors. II. Failure of thymosin to alter the natural history of nzb and nzb/nzw mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Effect of long-term treatment with circulating thymic factor on murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Effect of altered lymphocyte function on immunologic disorders in NZB/NZW mice. III. Acceleration of disease by thymosin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Loss of suppressor T cells in adult NZB/NZW mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Effect of calorie restriction on the production and responsiveness to interleukin 2 in (NZB X NZW)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Loss of Fc receptors for IgG from human T lymphocytes exposed to IgG immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Unusual characteristics of peritoneal macrophages from aged autoimmune-prone mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Systemic lupus erythematosus: causative factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Systemic lupus erythematosus--survival patterns. Experience with 609 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Glucocorticosteroid therapy: mechanisms of action and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Treatment of intractable rheumatoid arthritis with total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Leucapheresis in severe rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Lymphapheresis in rheumatoid arthritis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Therapeutic studies in NZB/NZW mice. VI. Age-dependent effects of concanavalin A stimulated spleen cell supernate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Increased survival of mice given multiple syngeneic young thymus grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Prostaglandin E 1 as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Prostaglandin E1 treatment of NZB/NZW mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Effect of Prostaglandin E1 on Adjuvant Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Renal prostaglandins in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Plasma exchange in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Plasmapheresis in the management of acute systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Reversal of lupus-erythematosus-like disease with danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

C-Type Virus Expression in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice I. Xenotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Type C virus expression and host response in diet-cured NZB/W mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

The multi-faceted zinc dependency of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Cyclosporin A for the treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Idiotypic networks and their possible exploitation for manipulation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Production of autoantibodies by human-human hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990184-8

7 January 2021

10.1016/S0140-6736(83)90184-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6135039%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference